Human gastrointestinal neoplasia-associated myofibroblasts can develop from bone marrow-derived cells following allogeneic stem cell transplantation

Stem Cells

Volumn 27, Issue 6, 2009, Pages 1463-1468

  Worthley, Daniel L ^a   Ruszkiewicz, Andrew ^b   Davies, Ruth ^b   Moore, Sarah ^b   Nivison Smith, Ian ^c   To, L Bik ^d   Browett, Peter ^e   Western, Robyn ^a   Durrant, Simon ^a   So, Jason ^f   Young, Graeme P ^g   Mullighan, Charles G ^h   Bardy, Peter G ^d,i   Michael, Michael Z ^g  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^c Australasian Bone Marrow Transplant Recipient Registry   (Australia)

^d ROYAL ADELAIDE HOSPITAL   (Australia)

^e UNIVERSITY OF AUCKLAND   (New Zealand)

^f UNIVERSITY OF HONG KONG   (Hong Kong)

^g FLINDERS UNIVERSITY   (Australia)

^h ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

ⁱ QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

Bone marrow transplantation; Cancer; Fibroblasts; Gastrointestinal neoplasms; Stromal cells

Indexed keywords

ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW; CONTROLLED STUDY; DISEASE REGISTRY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GASTROINTESTINAL TUMOR; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MYOFIBROBLAST; RECTUM ADENOMA; SKIN CANCER; STOMACH CANCER; STROMA CELL;

BONE MARROW TRANSPLANTATION; FEMALE; FIBROBLASTS; GASTROINTESTINAL NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; NEOPLASMS, SECOND PRIMARY; STROMAL CELLS; TRANSPLANTATION, HOMOLOGOUS;

EID: 67649592236     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.63     Document Type: Article

References (32)

1. Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer 2001;1:46-54. (Pubitemid 33741880)
2. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006;6:392-401.
3. Gaggioli C, Hooper S, Hidalgo-Carcedo C et al. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol 2007;9:1392-1400. (Pubitemid 350201752)
4. Houghton J, Stoicov C, Nomura S et al. Gastric cancer originating from bone marrow-derived cells. Science 2004;306:1568-1571. (Pubitemid 39564955)
5. Correa P, Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology 2007;133:659-672. (Pubitemid 47187360)
6. Kim BG, Li C, Qiao W et al. Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature 2006;441:1015-1019. (Pubitemid 43980359)
7. Ishikawa H, Nakao K, Matsumoto K et al. Bone marrow engraftment in a rodent model of chemical carcinogenesis but no role in the histogenesis of hepatocellular carcinoma. Gut 2004;53:884-889. (Pubitemid 38662141)
8. Marrache F, Pendyala S, Bhagat G et al. Role of bone marrow-derived cells in experimental chronic pancreatitis. Gut 2008;57:1113-1120.
9. Brittan M, Hunt T, Jeffery R et al. Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon. Gut 2002;50:752-757. (Pubitemid 34539034)
10. Peters BA, Diaz LA, Polyak K et al. Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat Med 2005;11:261-262. (Pubitemid 40460552)
11. Avital I, Moreira AL, Klimstra DS et al. Donor-derived human bone marrow cells contribute to solid organ cancers developing after bone marrow transplantation. Stem Cells 2007;25:2903-2909. (Pubitemid 350127875)
12. Cogle CR, Theise ND, Fu D et al. Bone marrow contributes to epithelial cancers in mice and humans as developmental mimicry. Stem Cells 2007;25:1881-1887. (Pubitemid 47258166)
13. Janin A, Murata H, Leboeuf C et al. Donor-derived oral squamous cell carcinoma after allogeneic bone marrow transplantation. Blood 2009;113:1834-1840.
14. de Perrot M, Wigle DA, Pierre AF et al. Bronchogenic carcinoma after solid organ transplantation. Ann Thorac Surg 2003;75:367-371. (Pubitemid 36184472)
15. Aractingi S, Kanitakis J, Euvrard S et al. Skin carcinoma arising from donor cells in a kidney transplant recipient. Cancer Res 2005;65:1755-1760. (Pubitemid 40478601)
16. Ishii G, Sangai T, Oda T et al. Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction. Biochem Biophys Res Commun 2003;309:232-240. (Pubitemid 37006422)
17. Direkze NC, Hodivala-Dilke K, Jeffery R et al. Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res 2004;64:8492-8495. (Pubitemid 39552057)
18. Zeisberg EM, Potenta S, Xie L et al. Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res 2007;67:10123-10128. (Pubitemid 350070783)
19. Zeisberg M, Yang C, Martino M et al. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 2007;282:23337-23347. (Pubitemid 47311952)
20. Mishra PJ, Mishra PJ, Humeniuk R et al. Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 2008;68:4331-4339.
21. Horwitz EM, Le Blanc K, Dominici M et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005;7:393-395. (Pubitemid 41671625)
22. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997;276:71-74. (Pubitemid 27161245)
23. Tondreau T, Meuleman N, Delforge A et al. Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: Proliferation, Oct4 expression, and plasticity. Stem Cells 2005;23:1105-1112.
24. Rieger K, Marinets O, Fietz T et al. Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cell or bone marrow transplantation. Exp Hematol 2005;33:605-611. (Pubitemid 40592178)
25. Bartsch K, Al-Ali H, Reinhardt A et al. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used. Transplantation 2009;87:217-221.
26. Villaron EM, Almeida J, Lopez-Holgado N et al. Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation. Haematologica 2004;89:1421-1427. (Pubitemid 39643507)
27. Poloni A, Leoni P, Buscemi L et al. Engraftment capacity of mesenchymal cells following hematopoietic stem cell transplantation in patients receiving reduced-intensity conditioning regimen. Leukemia 2005;20:329-335.
28. Thiele J, Varus E, Wickenhauser C et al. Mixed chimerism of cardiomyocytes and vessels after allogeneic bone marrow and stem-cell transplantation in comparison with cardiac allografts. Transplantation 2004;77:1902-1905. (Pubitemid 38822217)
29. Deb A, Wang S, Skelding KA et al. Bone marrow-derived cardiomyocytes are present in adult human heart: A study of gender-mismatched bone marrow transplantation patients. Circulation 2003;107:1247-1249. (Pubitemid 36314405)
30. Houghton J, Wang TC. Helicobacter pylori and gastric cancer: A new paradigm for inflammation-associated epithelial cancers. Gastroenterology 2005;128:1567-1578. (Pubitemid 40692553)
31. Pawelek JM. Tumour-cell fusion as a source of myeloid traits in cancer. Lancet Oncol 2005;6:988-993. (Pubitemid 41685232)
32. Wurmser AE, Gage FH. Stem cells: Cell fusion causes confusion. Nature 2002;416:485-487.